Iveric Bio Inc Reports Results For The Quarter Ended In March: Earnings Summary

IVERIC bio

10/05/2023 13:58

* IVERIC bio Inc  ISEE.OQ  reported a quarterly adjusted
loss
of 53 cents​​ per share for the quarter ended in March. The mean
expectation of nine analysts for the quarter was for a loss
of 47 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * IVERIC bio Inc's reported EPS for the quarter was a loss
of 53
cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * IVERIC bio Inc shares had risen by 53.5% this quarter and
gained 74.5% so far this year.
    * The company reported a quarterly loss of $72.23 million.
    * Wall Street's median 12-month price target for IVERIC bio
Inc is
$40.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 11
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 12:58 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.47          -0.53          Missed
 Dec. 31 2022      -0.37          -0.47          Missed
 Sep. 30 2022      -0.40          -0.35          Beat
 Jun. 30 2022      -0.31          -0.41          Missed